Comparison between different laboratory tests for the detection and prevention of heparin-induced thrombocytopenia

被引:26
作者
Vitale, M
Tazzari, P
Ricci, F
Mazza, MA
Zauli, G
Martini, G
Caimi, L
Manzoli, FA
Conte, R
机构
[1] Univ Parma, Inst Human Anat, I-43100 Parma, Italy
[2] CNR, Inst Cytomorphol, Inst Res, I-40126 Bologna, Italy
[3] St Orsola Marcello Malpighi Hosp, Immunohematol & Transfus Med Serv, Bologna, Italy
[4] Spedali Civil Brescia, Clin Pathol Lab, I-25125 Brescia, Italy
[5] Univ G dAnnunzio, Inst Human Morphol, Chieti, Italy
[6] Univ Brescia, Dept Biomed Sci & Biotechnol, Brescia, Italy
[7] Univ Bologna, Inst Human Anat, I-40126 Bologna, Italy
来源
CYTOMETRY | 2001年 / 46卷 / 05期
关键词
heparin-induced thrombocytopenia; flow cytometry; CD62p; annexin V; platelet activation;
D O I
10.1002/cyto.1170
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Heparin-induced thrombocytopenia (HIT) is a possible complication of heparin therapy that can evolve with life-threatening thromboembolism, for which early diagnosis is essential. However, the specific laboratory approach to the diagnosis of HIT is still controversial. Methods: Sera from 13 patients with HIT, from 15 patients with non-HIT thrombocytopenia, and from 10 normal subjects were used to compare nonfunctional and functional methods to detect anti-heparin:PF-4 antibodies and platelet activation. We used three enzyme-linked immunosorbent assays (ELISAs) and the particle gel immunoassay as nonfunctional tests, and platelet aggregometry, CD62p (p-selectin) phenotypical expression, and Annexin V binding as functional assays. Results: CD62p expression was positive in 85% of the cases and Annexin V was positive in 40% of the HIT cases examined. Aggregometry gave variable results that depend strongly on the donor. Conclusion: Functional tests for platelet activation are more reliable for HIT diagnosis than the nonfunctional tests. We conclude that the phenotypical expression of p-selectin detected by flow cytometry on activated platelets appears to he a good functional marker for the diagnosis of HIT and its possible thromboembolic complications. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:290 / 295
页数:6
相关论文
共 27 条
[1]  
Amiral J, 1996, AM J HEMATOL, V52, P90, DOI 10.1002/(SICI)1096-8652(199606)52:2<90::AID-AJH4>3.3.CO
[2]  
2-5
[3]   Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia [J].
Amiral, J ;
Wolf, M ;
Fischer, AM ;
BoyerNeumann, C ;
Vissac, AM ;
Meyer, D .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (04) :954-959
[4]   HEPARIN-INDUCED THROMBOCYTOPENIA AND THROMBOSIS [J].
ASTER, RH .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (20) :1374-1376
[5]   Platelet activation in patients after an acute coronary syndrome: Results from the TIMI-12 trial [J].
Ault, KA ;
Cannon, CP ;
Mitchell, J ;
McCahan, J ;
Tracy, RP ;
Novotny, WF ;
Reimann, JD ;
Braunwald, E .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (03) :634-639
[6]   Complexes of heparin and platelet factor 4 specifically stimulate T cells from patients with heparin-induced thrombocytopenia thrombosis [J].
Bacsi, S ;
De Palma, R ;
Visentin, GP ;
Gorski, J ;
Aster, RH .
BLOOD, 1999, 94 (01) :208-215
[7]   P-selectin and platelet clearance [J].
Berger, G ;
Hartwell, DW ;
Wagner, DD .
BLOOD, 1998, 92 (11) :4446-4452
[8]   Role of activation-dependent platelet membrane glycoproteins in development of subacute occlusive coronary stent thrombosis [J].
Gawaz, M ;
Neumann, FJ ;
Ott, I ;
May, A ;
Rudiger, S ;
Schomig, A .
CORONARY ARTERY DISEASE, 1997, 8 (3-4) :121-128
[9]  
Haas S, 1999, SEMIN THROMB HEMOST, V25, P67
[10]   PLATELET-AGGREGATION STUDIES FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA [J].
ISENHART, CE ;
BRANDT, JT .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1993, 99 (03) :324-330